[Eruptions in the course of immunologic reversions in lepromatous patients treated with immunomodulating agents].
D001500:BCG Vaccine / Q000627:therapeutic use*; D006801:Humans; D007916:Lepromin / Q000627:therapeutic use*; D007918:Leprosy / Q000276:immunology / Q000473:pathology* / Q000628:therapy
D001500:BCG Vaccine; D007916:Lepromin
Eruptions au cours des renversements immunologiques chez des lépromateux traités par des immunomodulants.